Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol.

Int J Chron Obstruct Pulmon Dis · 2017 · PMC5490469 · PMID 28694692

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

marginally significantP =0.08so close (0.05 < p ≤ 0.1)

The LOS difference was the same after adjusting for concomitant medication use anytime during hospitalization (instead of pre-index), and the difference was marginally significant (4.7 vs 4.9 days, P =0.08).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.